Ipilimumab vs Sacubitril-Valsartan

## Ipilimumab vs Sacubitril-Valsartan: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Sacubitril-Valsartan**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Sacubitril-Valsartan**: Angiotensin receptor-neprilysin inhibitor (ARNI) combining neprilysin inhibition with AT1 receptor blockade.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Sacubitril-Valsartan — 11.5 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Sacubitril-Valsartan — C24H29N2O5.

**Molecular Weight**: Ipilimumab — N/A; Sacubitril-Valsartan — 414.5010 g/mol.

**Type**: Ipilimumab — Antibody; Sacubitril-Valsartan — Small molecule.